日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DualPG-DTA: A Large Language Model-Powered Graph Neural Network Framework for Enhanced Drug-Target Affinity Prediction and Discovery of Novel CDK9 Inhibitors Exhibiting In Vivo Anti-Leukemia Activity

DualPG-DTA:一种基于大型语言模型的图神经网络框架,用于增强药物靶点亲和力预测和发现具有体内抗白血病活性的新型 CDK9 抑制剂。

Chen, Yihao; Huang, Jindi; Liu, Cong; Zhang, Shipeng; Li, Xinze; Zhang, Zhang; Chen, Tie-Gen; Wang, Ling

Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma

更正:HSP90-MYC-CDK9 网络驱动套细胞淋巴瘤的治疗耐药性

Yan, Fangfang; Jiang, Vivian; Jordan, Alexa; Che, Yuxuan; Liu, Yang; Cai, Qingsong; Xue, Yu; Li, Yijing; McIntosh, Joseph; Chen, Zhihong; Vargas, Jovanny; Nie, Lei; Yao, Yixin; Lee, Heng-Huan; Wang, Wei; Bigcal, JohnNelson R; Badillo, Maria; Meena, Jitendra; Flowers, Christopher; Zhou, Jia; Zhao, Zhongming; Simon, Lukas M; Wang, Michael

Corrigendum to "P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9" [Neoplasia, volume 23 (2021) 304325]

对“通过 ERK1/2 和 CDK9 对 ATF4 转录的调控,在 p53 突变的肿瘤中实现 p53 通路的 P53 非依赖性部分恢复”的更正 [Neoplasia,第 23 卷(2021 年)304325]

Tian, Xiaobing; Ahsan, Nagib; Lulla, Amriti; Lev, Avital; Abbosh, Philip; Dicker, David T; Zhang, Shengliang; El-Deiry, Wafik S

Corrigendum to "GBP1-CDK9-STAT3 signaling axis promotes osteosarcoma PD-L1 expression and immune escape" [Neoplasia 69 (2025) 101232]

对“GBP1-CDK9-STAT3 信号轴促进骨肉瘤 PD-L1 表达和免疫逃逸”的更正 [Neoplasia 69 (2025) 101232]

Jing, Doudou; Chen, Binghong; Liang, Ruqi; Li, Fei; Zhao, Bin; Pu, Feifei; Wu, Wei

Inhibition of CDK9 alleviates osteoarthritis by suppressing inflammation and reducing chondrocyte apoptosis

抑制 CDK9 可通过抑制炎症和减少软骨细胞凋亡来缓解骨关节炎

Zhang, Bo; Wu, Zebin; Wang, Wentao; Xu, Hao; Zhao, Yuhu; Zhang, Po; Xu, Yaozeng

Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition

干扰 CDK9 活性可抑制三阴性乳腺癌,而 EGFR 抑制剂可增强这种抑制作用。

van der Noord, Vera E; McLaughlin, Ronan P; Karuntu, Jessica S; He, Jichao; Timmermans, A Mieke; Basnet, Sunita K C; Long, Yi; Diab, Sarah Al Haj; Tadesse, Solomon; Proost, Natalie; van Gerwen, Bastiaan; Siteur, Bjørn; van de Ven, Marieke; Pont, Chantal; Le Dévédec, Sylvia E; Martens, John W M; Wang, Shudong; Zhang, Yinghui; van de Water, Bob

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine.

抑制 CDK9 可增强维奈托克和阿扎胞苷联合治疗诱导的 AML 细胞死亡。

Wu Shuangshuang, Zhao Jianlei, Azmi Aaban Asfar, Gupte Avanti, Thibodeau Jenna, Liu Shuang, Yang Jinli, Wang Guan, Edwards Holly, Polin Lisa A, Kushner Juiwanna, Dzinic Sijana H, White Kathryn, Boerner Julie, Hüttemann Maik, Yang Jay, Wang Yue, Taub Jeffrey W, Ge Yubin

Inhibition of CDK9 sensitizes multidrug resistant ovarian cancer cells to paclitaxel.

抑制 CDK9 可使多药耐药卵巢癌细胞对紫杉醇敏感。

Wang Jinglu, Hornicek Francis J, Shi Huirong, Feng Wenlong, Duan Zhenfeng

CDK9 interacts with a RanGTP-importin-β complex to regulate erythroid enucleation

CDK9 与 RanGTP-importin-β 复合物相互作用,调节红细胞核的排出。

Newton, Lucas M; Lim, Krystle Y B; Abeid, Donia Y; Wölwer, Christina B; Johnson, Chad J; Russell, Sarah M; Hawkins, Edwin D; Humbert, Patrick O

Novel biallelic CDK9 variants are associated with retinal dystrophy without CHARGE-like malformation syndrome

新型双等位基因 CDK9 变异与视网膜营养不良相关,但不伴有 CHARGE 样畸形综合征

Nishina, Sachiko; Torii, Kaoruko; Ishitani, Shizuka; Yoshida, Tomoyo; Fukami, Maki; Kurosawa, Kenji; Kosaki, Kenjiro; Saitsu, Hirotomo; Ishitani, Tohru; Hotta, Yoshihiro